Cerity Partners’s Core Scientific CORZ Stock Holding History

Cerity Partners’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$473K	Sell	18,502 -13	-0.1%	-$306	﹤0.01%	2467
2026 Q1	$277K	Buy	+18,515	New	+$316K	﹤0.01%	2667

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Cerity Partners's CORZ Position: Q2 2026 in Review

Cerity Partners reduced its Core Scientific (CORZ) stake by 0.07% in Q2 2026, selling an estimated $306 and leaving 18,502 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Cerity Partners first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Cerity Partners held 18,502 shares of Core Scientific worth $473K as of Q2 2026.
Cerity Partners sold 13 Core Scientific shares in Q2 2026, an estimated $306.
Core Scientific made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2467 holding.
Cerity Partners first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.